![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 32, 29649-29654, August 8, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
by Controlled Proteolysis*







¶
From the
Laboratory of Structural Biology, NIEHS,
National Institutes of Health, Research Triangle Park, North Carolina 27709
and the
Section on DNA Replication, Repair, and
Mutagenesis, NICHD, National Institutes of Health, Bethesda, Maryland
20892
Human DNA polymerase
(pol
) is a member of the Y-family of low
fidelity lesion bypass DNA polymerases. In addition to a probable role in DNA
lesion bypass, this enzyme has recently been shown to be required for somatic
hypermutation in human B-cells. We found earlier that human pol
has
deoxyribose phosphate (dRP) lyase activity and unusual specificity for
activity during DNA synthesis, suggesting involvement in specialized forms of
base excision repair (BER). Here, mapping of the domain structure of human pol
by controlled proteolysis revealed that the enzyme has a 48-kDa
NH2-terminal domain and a protease resistant 40-kDa "core
domain" spanning residues Met79 to
Met445. A
covalently cross-linked pol
-DNA complex, representing a trapped
intermediate in the dRP lyase reaction, was subjected to controlled
proteolysis. Cross-linking was mapped to the 40-kDa core domain, indicating
that the dRP lyase active site is in this region. To further evaluate the BER
capacity of the enzyme, the dRP lyase and DNA polymerase activities were
characterized on DNA substrates representing BER intermediates, and we found
that pol
was able to complement the in vitro single-nucleotide
BER deficiency of a DNA polymerase
null cell extract.
Received for publication, May 22, 2003
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: 111 T.W. Alexander Dr., P. O. Box 12233, MD B2-06, Research Triangle Park, NC 27709. Tel.: 919-541-3267; Fax: 919-541-3592; E-mail: wilson5{at}niehs.nih.gov.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. N. Kundu, R. Balusu, A. S. Jaiswal, and S. Narayan Adenomatous polyposis coli-mediated hypersensitivity of mouse embryonic fibroblast cell lines to methylmethane sulfonate treatment: implication of base excision repair pathways Carcinogenesis, October 1, 2007; 28(10): 2089 - 2095. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Trivedi, K. H. Almeida, J. L. Fornsaglio, S. Schamus, and R. W. Sobol The Role of Base Excision Repair in the Sensitivity and Resistance to Temozolomide-Mediated Cell Death Cancer Res., July 15, 2005; 65(14): 6394 - 6400. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Haracska, L. Prakash, and S. Prakash A mechanism for the exclusion of low-fidelity human Y-family DNA polymerases from base excision repair Genes & Dev., November 15, 2003; 17(22): 2777 - 2785. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |